Table 6.
Post COVID-19 sequels that differentially reported at 28 days and 1 year after infection
| Sequelae | Variables | Percentagea | χ2 p-value | Odds ratio | 95% CI | p-value |
|---|---|---|---|---|---|---|
| Delta-infected group | ||||||
| Forgetfulness | Day 28 | 2.2% | 0.001* | 0.062 | 0.007–0.516 | 0.010* |
| Year 1 | 26.5% | |||||
| Hair loss | Day 28 | 0.0% | <0.001* | - | - | - |
| Year 1 | 38.2% | |||||
| Omicron-infected group | ||||||
| Cough | Day 28 | 29.3% | 0.021* | 4.552 | 1.168–17.734 | 0.029* |
| Year 1 | 8.3% | |||||
| Fatigue | Day 28 | 29.3% | 0.007* | 7.034 | 1.454–34.043 | 0.015* |
| Year 1 | 5.6% | |||||
| All participants | ||||||
| Forgetfulness at year 1 | Delta | 26.5% | 0.044* | 3.960 | 0.970–16.158 | 0.055 |
| Omicron | 8.3% | |||||
| Hair loss at year 1 | Delta | 38.2% | 0.003* | 6.810 | 1.731–26.782 | 0.006* |
| Omicron | 8.3% | |||||
| Male | 10.3% | 0.036* | 0.249 | 0.064–0.972 | 0.045* | |
| Female | 31.7% | |||||
| Headache at year 1 | Delta | 11.8% | 0.034* | - | - | - |
| Omicron | 0.0% | |||||
| Joint pain at day 28 | Age ≥ 60 | 12.9% | 0.006* | - | - | - |
| Age 18–59 | 0.0% | |||||
| Forgetfulness at day 28 | Male | 0.0% | 0.025* | - | - | - |
| Female | 12.2% | |||||
| Joint pain at year 1 | Male | 0.0% | 0.031* | - | - | - |
| Female | 14.6% | |||||
| Adjusted odds ratio | ||||||
| Hair loss at year 1 | Delta | 8.678 | 2.055–36.652 | 0.003* | ||
| Omicron | ||||||
| Male | 0.181 | 0.042–0.783 | 0.022* | |||
| Female | ||||||
a, Percentage of participants presented with the sequelae in each variable category; *, statistically significant at p ≤ 0.05